Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D I Wright

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Seminars in Vascular Surgery|August 6, 2010
What is the current role of foam sclerotherapy in treating reflux and varicosities?David D I Wright
Perspectives in Vascular Surgery and Endovascular Therapy|July 16, 2009
The ESCHAR trial: should it change practice?David D I Wright
The New England Journal of Medicine|August 9, 2008
More on microembolism and foam sclerotherapyJanet E Rush, David D I Wright
The Patient|March 27, 2016
Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) InstrumentDavid D I Wright, Jean Paty, Diane M Turner-Bowker, et al.
Journal of Materials Science. Materials in Medicine|October 10, 2015
The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein modelDario Carugo, Dyan N Ankrett, Vincent O'Byrne, et al.
Journal of Vascular Surgery|September 25, 2010
Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shuntJohn D Regan, Kathleen D Gibson, Janet E Rush, et al.
Journal of Materials Science. Materials in Medicine|March 21, 2013
A novel biomimetic analysis system for quantitative characterisation of sclerosing foams used for the treatment of varicose veinsDario Carugo, Dyan N Ankrett, Vincent O'Byrne, et al.
Phlebology|June 4, 2015
Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foamsDario Carugo, Dyan N Ankrett, Xuefeng Zhao, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Seminars in Vascular Surgery|August 6, 2010
What is the current role of foam sclerotherapy in treating reflux and varicosities?David D I Wright
Perspectives in Vascular Surgery and Endovascular Therapy|July 16, 2009
The ESCHAR trial: should it change practice?David D I Wright
The New England Journal of Medicine|August 9, 2008
More on microembolism and foam sclerotherapyJanet E Rush, David D I Wright
The Patient|March 27, 2016
Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) InstrumentDavid D I Wright, Jean Paty, Diane M Turner-Bowker, et al.
Journal of Materials Science. Materials in Medicine|October 10, 2015
The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein modelDario Carugo, Dyan N Ankrett, Vincent O'Byrne, et al.
Journal of Vascular Surgery|September 25, 2010
Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shuntJohn D Regan, Kathleen D Gibson, Janet E Rush, et al.
Journal of Materials Science. Materials in Medicine|March 21, 2013
A novel biomimetic analysis system for quantitative characterisation of sclerosing foams used for the treatment of varicose veinsDario Carugo, Dyan N Ankrett, Vincent O'Byrne, et al.
Phlebology|June 4, 2015
Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foamsDario Carugo, Dyan N Ankrett, Xuefeng Zhao, et al.
Pageof 1